Magnetar Financial’s Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share IBER.WS Stock Holding History

Magnetar Financial’s Portfolio IBER.WS Stock Details IBER.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-163,916	Closed	-$2K	–	892
2022 Q4	$2K	Sell	163,916 -182,079	-53%	-$5.74K	﹤0.01%	753
2022 Q3	$34K	Buy	345,995 +322,020	+1,343%	+$34.5K	﹤0.01%	1001
2022 Q2	$2	Buy	+23,975	New	+$4.14K	﹤0.01%	1627

Other funds holding IBER.WS

LCM

Lynwood Capital Management Toronto, Ontario, Canada $16.9M AUM 19.31% 1-Year Est. Return

Magnetar Financial's IBER.WS Position: Q1 2023 in Review

Magnetar Financial sold out of Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share (IBER.WS) in Q1 2023, closing a stake of 163,916 shares — an estimated $2K sold.

Magnetar Financial first reported a position in IBER.WS in Q2 2022 and held it in 3 quarters. The position peaked at $34K in Q3 2022. 1 fund tracked by Wall St. Rank holds IBER.WS as of Q1 2023.

Magnetar Financial reported no remaining Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position as of Q1 2023 after selling out during the quarter.
Magnetar Financial sold 163,916 Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share shares in Q1 2023, an estimated $2K.
Magnetar Financial first reported a position in Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in Q2 2022 and held it in 3 quarters.
Magnetar Financial's Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position peaked at $34K in Q3 2022.
1 fund tracked by Wall St. Rank held Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share as of Q1 2023.

Based on Magnetar Financial's 13F filing for Q1 2023, filed 15 May 2023.